- Home
- ZBH vs BNTX Comparison
ZBH vs BNTX Comparison
Compare ZBH & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBH
- BNTX
- Stock Information
- Founded
- ZBH 1927
- BNTX 2008
- Country
- ZBH United States
- BNTX Germany
- Employees
- ZBH N/A
- BNTX N/A
- Industry
- ZBH Industrial Specialties
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZBH Health Care
- BNTX Health Care
- Exchange
- ZBH Nasdaq
- BNTX Nasdaq
- Market Cap
- ZBH 21.9B
- BNTX 23.9B
- IPO Year
- ZBH N/A
- BNTX 2019
- Fundamental
- Price
- ZBH $113.21
- BNTX $91.06
- Analyst Decision
- ZBH Buy
- BNTX Strong Buy
- Analyst Count
- ZBH 22
- BNTX 17
- Target Price
- ZBH $124.15
- BNTX $146.17
- AVG Volume (30 Days)
- ZBH 1.8M
- BNTX 911.2K
- Earning Date
- ZBH 05-01-2025
- BNTX 03-10-2025
- Dividend Yield
- ZBH 0.85%
- BNTX N/A
- EPS Growth
- ZBH N/A
- BNTX N/A
- EPS
- ZBH 4.43
- BNTX N/A
- Revenue
- ZBH $7,678,600,000.00
- BNTX $2,848,224,455.00
- Revenue This Year
- ZBH $3.68
- BNTX N/A
- Revenue Next Year
- ZBH $4.53
- BNTX N/A
- P/E Ratio
- ZBH $25.54
- BNTX N/A
- Revenue Growth
- ZBH 3.85
- BNTX N/A
- 52 Week Low
- ZBH $97.69
- BNTX $76.53
- 52 Week High
- ZBH $131.61
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ZBH 62.40
- BNTX 33.11
- Support Level
- ZBH $109.33
- BNTX $93.48
- Resistance Level
- ZBH $112.31
- BNTX $101.69
- Average True Range (ATR)
- ZBH 2.47
- BNTX 3.69
- MACD
- ZBH 0.20
- BNTX -0.28
- Stochastic Oscillator
- ZBH 93.05
- BNTX 29.59
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.